Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership50,872 shares
Latest Disclosed Value $ 3,352,967
Advisor Group Holdings, Inc. ownership in 1CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 50,872 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $2,747,088 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 52,436 shares of Cytokinetics, Incorporated. This represents a change in shares of -2.98% during the quarter. The current value of the position is $3,170,343 USD.

Advisor Group Holdings, Inc. has a history of taking positions in derivatives of the underlying security (1CYTK) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 50,872 -1,564 -2.98 3,353 0.63 0.0029
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 52,436 -2,297 -4.20 3,332 14.59 0.0049
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 54,733 48,820 825.64 2,908 1,390.77 0.0041
2025-09-04 2025-06-30 13F/A-1 YTOKINETICS COM NEW 23282W605 5,913 833 16.40 196 -4.41 0.0003
2025-08-13 2025-06-30 13F YTOKINETICS COM NEW 23282W605 5,872 792 268 0.0003
2025-05-12 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 5,080 -669 -11.64 204 -21.24 0.0005
2025-06-06 2024-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 5,749 260 4.74 259 -10.38 0.0006
2025-02-07 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 3,018 -2,471 145 0.0004
2024-11-13 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 5,489 2,974 118.25 290 112.50 0.0007
2024-08-13 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 2,515 -268 -9.63 136 -30.26 0.0003
2024-05-10 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 2,783 -3,776 -57.57 195 -64.35 0.0004
2024-02-12 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 6,559 -376 -5.42 548 168.14 0.0010
2023-11-13 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 6,935 1,474 26.99 204 10.87 0.0003
2023-08-21 2023-06-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 5,461 274 5.28 184 1.10 0.0003
2023-08-10 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 5,461 274 184 0.0000
2023-05-12 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 5,187 -99 -1.87 182 -24.48 0.0003
2023-02-10 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 5,286 -4,347 -45.13 242 -48.39 0.0005
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 9,633 -15,553 -61.75 467 -52.92 0.0011
2022-08-10 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 25,186 19,256 324.72 992 544.16 0.0022
2022-05-04 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 5,930 767 14.86 154 -34.47 0.0003
2022-02-03 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 5,163 979 23.40 235 55.63 0.0004
2021-11-05 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 4,184 87 2.12 151 81.93 0.0003
2021-08-02 2021-06-30 13F CYTOKINETICS COM NEW 23282W605 4,097 196 5.02 83 -9.78 0.0002
2021-05-13 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 3,901 1,176 43.16 92 67.27 0.0002
2021-02-10 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 2,725 1,342 97.04 55 66.67 0.0001
2020-11-12 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 1,383 0 0.00 33 0.00 0.0001
2020-08-14 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 1,383 -106 -7.12 33 83.33 0.0001
2020-05-18 2020-03-31 13F CYTOKINETICS COM NEW 23282W605 1,489 1,489 18 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F CYTOKINETICS CALL Call 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F CYTOKINETICS CALL Call 1 0.00 0 n/a n/a n/a
2025-09-04 2025-06-30 13F/A CYTOKINETICS CALL Call 1 0.00 0 n/a n/a n/a
2025-08-13 2025-06-30 13F CYTOKINETICS CALL Call 1 1 n/a n/a n/a
2025-05-12 2025-03-31 13F CYTOKINETICS CALL Call 1 0.00 1 -100.00 n/a n/a n/a
2025-06-06 2024-12-31 13F/A CYTOKINETICS CALL Call 1 0.00 1 0.00 n/a n/a n/a
2025-02-07 2024-12-31 13F CYTOKINETICS CALL Call 1 2 n/a n/a n/a
2024-11-13 2024-09-30 13F CYTOKINETICS CALL Call 1 0.00 2 0.00 n/a n/a n/a
2024-08-13 2024-06-30 13F CYTOKINETICS CALL Call 1 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.